TY - JOUR
T1 - Downregulation of CD3z in NK cells from systemic lupus erythematosus patients confers a proinflammatory phenotype
AU - Suárez-Fueyo, Abel
AU - Bradley, Sean J.
AU - Katsuyama, Takayuki
AU - Solomon, Sarah
AU - Katsuyama, Eri
AU - Kyttaris, Vasileios C.
AU - Moulton, Vaishali R.
AU - Tsokos, George C.
N1 - Funding Information:
This work was supported by National Institutes of Health Grants R01 AI042269 (to G.C.T.) and R01 AR060849 (to V.C.K.) and National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants K01 AR060781 and R01 AR068974 (to V.R.M.). A.S.-F. and S.J.B. were supported by National Institutes of Health Training Grant T32 AI074549 (to G.C.T.). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
Copyright © 2018 by The American Association of Immunologists, Inc.
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Cytotoxic function and cytokine profile of NK cells are compromised in patients with systemic lupus erythematosus (SLE). CD3z, an important molecule for NK cell activation, is downregulated in SLE T cells and contributes to their altered function. However, little is known about the role of CD3z in SLE NK cells. We studied CD3z levels and its contribution to cytotoxic, degranulation, and cytokine production capacity of NK cells from patients with SLE. Furthermore, we studied the human NK cell line, NKL, in which manipulation of CD3z levels was achieved using small interfering RNA and NK cells from Rag2 mice deficient in CD3z. We found reduced CD3z expression in NK cells from SLE patients independent of disease activity. Downregulation of CD3z expression in NK cells is mediated, at least in part, by Caspase 3, the activity of which is higher in NK cells from patients with SLE compared with NK cells from healthy donors. CD3z levels correlated inversely with natural cytotoxicity and the percentage of cells capable of producing the proinflammatory cytokines IFN-g and TNF. In contrast, CD3z levels showed a direct correlation with levels of Ab-dependent cellular cytotoxicity. Experiments performed in CD3z-silenced NKL and CD3z-deficient NK cells from Rag2 mice confirmed the dependence of NK cell function on CD3z levels. Our results demonstrate a differential role for CD3z in natural cytotoxicity and Ab-dependent cellular cytotoxicity. We conclude that downregulated CD3z confers a proinflammatory phenotype to SLE NK cells and contributes to their altered function in patients with SLE. The Journal of Immunology, 2018, 200: 3077–3086.
AB - Cytotoxic function and cytokine profile of NK cells are compromised in patients with systemic lupus erythematosus (SLE). CD3z, an important molecule for NK cell activation, is downregulated in SLE T cells and contributes to their altered function. However, little is known about the role of CD3z in SLE NK cells. We studied CD3z levels and its contribution to cytotoxic, degranulation, and cytokine production capacity of NK cells from patients with SLE. Furthermore, we studied the human NK cell line, NKL, in which manipulation of CD3z levels was achieved using small interfering RNA and NK cells from Rag2 mice deficient in CD3z. We found reduced CD3z expression in NK cells from SLE patients independent of disease activity. Downregulation of CD3z expression in NK cells is mediated, at least in part, by Caspase 3, the activity of which is higher in NK cells from patients with SLE compared with NK cells from healthy donors. CD3z levels correlated inversely with natural cytotoxicity and the percentage of cells capable of producing the proinflammatory cytokines IFN-g and TNF. In contrast, CD3z levels showed a direct correlation with levels of Ab-dependent cellular cytotoxicity. Experiments performed in CD3z-silenced NKL and CD3z-deficient NK cells from Rag2 mice confirmed the dependence of NK cell function on CD3z levels. Our results demonstrate a differential role for CD3z in natural cytotoxicity and Ab-dependent cellular cytotoxicity. We conclude that downregulated CD3z confers a proinflammatory phenotype to SLE NK cells and contributes to their altered function in patients with SLE. The Journal of Immunology, 2018, 200: 3077–3086.
UR - http://www.scopus.com/inward/record.url?scp=85046252649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046252649&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1700588
DO - 10.4049/jimmunol.1700588
M3 - Article
C2 - 29602774
AN - SCOPUS:85046252649
SN - 0022-1767
VL - 200
SP - 3077
EP - 3086
JO - Journal of Immunology
JF - Journal of Immunology
IS - 9
ER -